{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:02:54Z","timestamp":1772121774960,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.ygyno.2013.01.025","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T15:34:37Z","timestamp":1359992077000},"page":"304-309","source":"Crossref","is-referenced-by-count":19,"title":["A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I\u2013IIIA (1988) uterine papillary serous carcinoma of the endometrium"],"prefix":"10.1016","volume":"129","author":[{"given":"Anuja","family":"Jhingran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lois M.","family":"Ramondetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane C.","family":"Bodurka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian M.","family":"Slomovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jubilee","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence B.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.","family":"Eifel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen H.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0005","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ygyno.2004.08.019","article-title":"Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium","volume":"95","author":"Creasman","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.025_bb0020","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.ijrobp.2004.01.044","article-title":"The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma","volume":"59","author":"Kwon","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0025","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ygyno.2003.08.018","article-title":"Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases","volume":"91","author":"Slomovitz","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.025_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0035","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0090-8258(03)00199-9","article-title":"Improved outcome at 10years for serous-papillary\/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation","volume":"90","author":"Martinez","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0040","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1006\/gyno.1996.0070","article-title":"Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide","volume":"60","author":"Chambers","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0045","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0090-8258(92)90224-7","article-title":"Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC)","volume":"46","author":"Levenback","year":"1992","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0050","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/gyno.1993.1308","article-title":"Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC)","volume":"51","author":"Price","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0055","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/gyno.1999.5444","article-title":"The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma","volume":"74","author":"Zanotti","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.025_bb0060","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/gyno.2001.6211","article-title":"Treatment of uterine papillary serous carcinoma with paclitaxel","volume":"82","author":"Ramondetta","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1016\/j.ygyno.2013.01.025_bb0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/jnci\/86.6.441","article-title":"In vitro studies of Taxol as a radiation sensitizer in human tumor cells","volume":"86","author":"Liebmann","year":"1994","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0070","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(92)90888-O","article-title":"Taxol: a novel radiation sensitizer","volume":"22","author":"Tishler","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ygyno.2013.01.025_bb0075","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/nm0196-72","article-title":"Loss of normal p53 function confers sensitization to Taxol by increasing G2\/M arrest and apoptosis","volume":"2","author":"Wahl","year":"1996","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0080","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1006\/gyno.1997.4851","article-title":"Phase I trial of Taxol as a radiation sensitizer with cisplatin in advanced cervical cancer","volume":"67","author":"Chen","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"6 Suppl. 16","key":"10.1016\/j.ygyno.2013.01.025_bb0085","first-page":"128","article-title":"Weekly paclitaxel with and without concurrent radiation therapy: toxicity, pharmacokinetics, and response","volume":"23","author":"Glantz","year":"1996","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0090","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1200\/JCO.1997.15.3.901","article-title":"Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study","volume":"15","author":"Safran","year":"1997","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ygyno.2013.01.025_bb0095","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"issue":"10","key":"10.1016\/j.ygyno.2013.01.025_bb0100","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygyno.2007.10.037","article-title":"Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)","volume":"108","author":"Goldberg","year":"2008","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0155","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.09.005","article-title":"The importance of chemotherapy and radiation in uterine papillary serous carcinoma","volume":"123","author":"Viswanathan","year":"2011","journal-title":"Gynecol Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0160","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2004.08.030","article-title":"Patients with uterine papillary serous cancers may benefit from adjuvant platinum-based chemoradiation","volume":"95","author":"Kelly","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.radonc.2009.08.042","article-title":"IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy","volume":"93","author":"Alongi","year":"2009","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0120","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2006.01.062","article-title":"Clinical outcome with adjuvant treatment of endometrial carcinoma using intensity-modulated radiation therapy","volume":"102","author":"Beriwal","year":"2006","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ygyno.2013.01.025_bb0125","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/PPO.0b013e318173a04b","article-title":"Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients","volume":"14","author":"Chen","year":"2008","journal-title":"Cancer J"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.025_bb0130","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/S0360-3016(01)02785-7","article-title":"Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies","volume":"52","author":"Mundt","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ygyno.2013.01.025_bb0135","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/S0360-3016(03)00325-0","article-title":"Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy","volume":"56","author":"Mundt","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0140","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2003.05.001","article-title":"A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy","volume":"69","author":"Roeske","year":"2003","journal-title":"Radiother Oncol"},{"issue":"9717","key":"10.1016\/j.ygyno.2013.01.025_bb0145","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ygyno.2013.01.025_bb0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2004.05.009","article-title":"High-dose rate brachytherapy for stage I\/II papillary serous or clear cell endometrial cancer","volume":"94","author":"DuBeshter","year":"2004","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825813000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:21:54Z","timestamp":1539897714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825813000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0090825813000620"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2013.01.025","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717985089.793474102","asserted-by":"object"}]},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}